Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell. 2010 Jan 22;140(2):180-2. doi: 10.1016/j.cell.2010.01.013.

The brothers RAF.

Author information

1
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

Abstract

Targeted molecular therapies for cancer treatment have shown promise, but also have limitations. In this issue, Heidorn et al. (2010) find that a class of targeted molecular therapies with clinical effectiveness against one melanoma subtype may have adverse clinical effects in another.

PMID:
20141832
DOI:
10.1016/j.cell.2010.01.013
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center